Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 115 results
Author
Title
Type
Year
2016
Elemento O
,
Rubin MA
. 2016.
Genomic Testing & Precision Medicine: Bigger Is Better
.
Zhong Q
,
Rüschoff JH
,
Guo T
,
Gabrani M
,
Schüffler PJ
,
Rechsteiner M
,
Liu Y
,
Fuchs TJ
,
Rupp NJ
,
Fankhauser C
et al.
. 2016.
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.
.
Sci Rep. 6:24146.
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
.
N Engl J Med.
Gillessen S
,
Omlin A
,
Attard G
,
de Bono JS
,
Efstathiou E
,
Fizazi K
,
Halabi S
,
Nelson PS
,
Sartor O
,
Smith MR
et al.
. 2016.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
.
Ann Oncol.
Ceder Y
,
Bjartell A
,
Culig Z
,
Rubin MA
,
Tomlins S
,
Visakorpi T
. 2016.
The Molecular Evolution of Castration-resistant Prostate Cancer
.
European Urology Focus.
Dardenne E
,
Beltran H
,
Benelli M
,
Gayvert K
,
Berger A
,
Puca L
,
Cyrta J
,
Sboner A
,
Noorzad Z
,
MacDonald T
et al.
. 2016.
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
.
Cancer Cell. 30(4):563-577.
Evans JR
,
Zhao SG
,
S Chang L
,
Tomlins SA
,
Erho N
,
Sboner A
,
Schiewer MJ
,
Spratt DE
,
Kothari V
,
Klein EA
et al.
. 2016.
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
.
JAMA Oncol. :1-10.
Beltran H
,
Danila D
,
B M
,
Szmulewitz R.
,
Vaishampayan U
,
Armstrong A.
,
Stein M.
,
Hoimes C
,
Pinski J.
,
Scher H.
et al.
. 2016.
A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC)
.
Khurana E
,
Fu Y
,
Chakravarty D
,
Demichelis F
,
Rubin MA
,
Gerstein M
. 2016.
Role of non-coding sequence variants in cancer.
.
Nat Rev Genet. 17(2):93-108.
Schlick B
,
Massoner P
,
Lueking A
,
Charoentong P
,
Blattner M
,
Schaefer G
,
Marquart K
,
Theek C
,
Amersdorfer P
,
Zielinski D
et al.
. 2016.
Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.
.
PLoS One. 11(2):e0147739.
2017
Sailer V
,
Pauli C
,
Merzier EC
,
Mosquera JMiguel
,
Beltran H
,
Rubin MA
,
Rao RA
. 2017.
On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study.
.
Anticancer Res. 37(4):1569-1573.
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Imielinski M
,
Rubin MA
. 2017.
Prostate cancer: Clinical hallmarks in whole cancer genomes.
.
Nat Rev Clin Oncol.
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
Blattner M
,
Liu D
,
Robinson BD
,
Huang D
,
Poliakov A
,
Gao D
,
Nataraj S
,
Deonarine LD
,
Augello MA
,
Sailer V
et al.
. 2017.
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
.
Cancer Cell. 31(3):436-451.
« first
‹ previous
1
2
3
4
5
(current)